It has been shown that suppression of bromodomain-containing protein 4 (BRD4) via pharmacological BET-specific bromodomain (BD) inhibitors can effectively block Myc expression in multiple cancers.25 To determine the role of BRD4, we examined the effect of BET inhibition on EREG-mediated PDL1 induction. This evidence concerns the gene MYC and cancer.